Xencor, Inc.
PosiFunda Ratios Only on PositoAI
PositoAI's own ratios from Xencor, Inc.'s yearly results (2022–2025), compared with Healthcare companies in United States. Tap ? on any ratio for what it means.
What stands out
- Tangible Net Worth Ratio: Of every $100 of net worth, $99 is tangible; the rest is goodwill and other intangibles, often from buying other companies. More tangible than 91% of Healthcare companies in United States.
- Tangible Assets Ratio: Of every $100 the company owns, $99 is in tangible assets such as plants, cash, stock and receivables; the rest is goodwill and other intangibles. More tangible than 89% of Healthcare companies in United States.
Where $100 of sales goes
Latest year (Dec 2025). Taxes and other income are not shown, so the parts need not add up to 100.
Cash quality
Profit Cash Ratio
—Loss-making or profit too small
Over the last 3 years profit was a loss or under 2% of sales, so cash per 100 of profit is not meaningful.
Self-Funding Ratio
-12.2×Over the last 3 years operating cash was negative while the company kept spending on investment (capex).
Lower than 53% of Healthcare companies in United States.
Cash Locked Ratio
—Data incomplete
Growth quality
Steadiness Ratio
2/3 · 1/3Sales grew in 2 of the last 3 years; profit grew in 1 of 3.
Steadier than 50% of Healthcare companies in United States.
Growth Efficiency Ratio
—Sales fell 24%
Sales fell 24% in 3 years, so extra profit per extra sales cannot be measured.
Asset Productivity Ratio
-24% / +3%In 3 years sales changed by -24% while total assets changed by +3%. Assets grew faster than sales.
Balance-sheet strength
Debt Due Cover Ratio
-3.1×Operating cash was negative last year, while some debt falls due within a year.
Higher than 62% of Healthcare companies in United States.
Cash Cushion Ratio
+19%Cash, after subtracting all debt, equals 19% of its market value (net cash).
Higher than 61% of Healthcare companies in United States.
Tangible Assets Ratio
99%Of every $100 the company owns, $99 is in tangible assets such as plants, cash, stock and receivables; the rest is goodwill and other intangibles.
More tangible than 89% of Healthcare companies in United States.
Tangible Net Worth Ratio
99%Of every $100 of net worth, $99 is tangible; the rest is goodwill and other intangibles, often from buying other companies.
More tangible than 91% of Healthcare companies in United States.
Shareholders
Standard fundamentals
P/E, P/B, ROE, debt, growth and more (13)
Xencor, Inc. made a loss over the last year. Xencor, Inc. owes $0.31 for every $1 it owns. Xencor, Inc. made a loss in each of the last two years.
Compared with Healthcare companies in United States · latest annual results Dec 2025.
P/E ratio
LossXencor, Inc. made a loss over the last year, so its P/E ratio is not meaningful.
P/B ratio
3.82The share price is 3.82 times Xencor, Inc.'s book value per share, higher than 64% of Healthcare companies in United States.
Market cap
$1.9 BThe total market value of all of Xencor, Inc.'s shares at today's price (share price × number of shares), larger than 74% of Healthcare companies in United States. PosiCap size class: Meso Cap.
Net worth (book value)
$503 MWhat Xencor, Inc. would have left on paper if it sold everything it owns and paid everything it owes, from its latest balance sheet (30 Jun 2026).
Book value per share
$6.77Net worth divided by the number of shares. The share price of $25.84 is 3.8 times this, which is the P/B above.
Return on equity (ROE)
-29.1%Xencor, Inc. lost 29.1% of its shareholders' money over the last year, higher than 61% of Healthcare companies in United States.
Owes vs Owns
0.31×Xencor, Inc. owes $0.31 for every $1 it owns (low), lower than 60% of Healthcare companies in United States.
Dividend yield
NoneXencor, Inc. does not currently pay a dividend.
Revenue growth
+14%Revenue rose 14% in the year to Dec 2025, and shrank 9% a year on average over 3 years.
Profit growth
LossXencor, Inc. made a loss in each of the last two years.
Profit margin
-73.2%Xencor, Inc. lost $73 for every $100 of revenue.
Interest cover
Not coveredXencor, Inc.'s operating profit did not cover its interest costs in the year to Dec 2025.
Cash vs debt
Net cashXencor, Inc. held $360 M more cash than debt (net cash) at Dec 2025.
Questions
How is P/B calculated on PositoAI?
P/B is market cap divided by net worth from the latest balance sheet. For Xencor, Inc.: $1.9 B ÷ $503 M (30 Jun 2026) = 3.8.
What is Xencor, Inc.'s return on equity?
Xencor, Inc. lost 29.1% of its shareholders' money over the last year, higher than 61% of Healthcare companies in United States.
How much does Xencor, Inc. owe compared with what it owns?
Xencor, Inc. owes $0.31 for every $1 it owns (low), lower than 60% of Healthcare companies in United States.
Does Xencor, Inc. pay a dividend?
No. Xencor, Inc. does not currently pay a dividend.
Is Xencor, Inc.'s revenue growing?
Revenue rose 14% in the year to Dec 2025, and shrank 9% a year on average over 3 years.
Figures from the company's yearly results and PositoAI's own data. Full tables are on the Go Deep tab. What each figure means. PositoAI is for research and education only and is not investment advice.